Domain‐Specific Olfaction in Children and Adults in the Era of Modulator Therapy for Cystic Fibrosis
Pediatric Pulmonology · 2025
DOI: 10.1002/ppul.71348 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Pulmonology, 2025. Verfasst von Jeremy P Tervo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology - Head and Neck Surgery, Columbia University Irving Medical Center, New York, New York, USA. Hauptthemen laut MEDLINE: Cystic Fibrosis, Olfaction Disorders, Smell. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: This research was supported by the National Center for Advancing Translational Sciences (NCATS), the National Heart, Lung, and Blood Institute (NHLBI), and the…, National Center for Advancing Translational Sciences.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Little is known about when people with cystic fibrosis (PwCF) begin to experience olfactory decline, or whether sustained use of novel highly effective modulator therapies (HEMT) is predictive of better olfaction. This study evaluated psychophysical olfactory performance and HEMT‐associated olfactory outcomes in children and adults with CF.
Methods
In this cross‐sectional installment of a longitudinal study, individuals with a physician‐confirmed diagnosis of CF completed questionnaires and psychophysical olfactory assessment (i.e., standardized assessment of olfactory domains involving a battery of olfactory stimuli). HEMT consisted of either elexacaftor‐tezacaftor‐ivacaftor (ETI) or vezacaftor‐tezacaftor‐deuivacaftor (VTD). Analysis compared performance between pediatric versus adult cohorts and assessed the impact of HEMT on psychophysical olfactory performance while controlling for age, sex, genotype, and history of sinus surgery.
Results
Individuals < 21 years old had better psychophysical olfactory performance than those ≥ 21 years old (61% vs. 24% normosmia). Younger age at the start of HEMT was not associated with lowered odds of threshold hyposmia [OR: 0.73; 95% CI: (0.34, 1.50)] or identification hyposmia [OR: 0.67; 95% CI: (0.35, 1.22)] within this cohort.
Conclusion
Younger people with CF appear to have relatively preserved psychophysical olfactory function that appears to prematurely decline through early adulthood compared to the general population. Although younger age at the start of HEMT therapy was not associated with better olfactory outcomes, future prospective longitudinal studies could evaluate individuals′ olfaction across their lifespan to assess the full impact of HEMT on olfaction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology - Head and Neck Surgery, Columbia University Irving Medical Center, New York, New York, USA.
- Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.
- Department of Pulmonology, Columbia University Irving Medical Center, New York, New York, USA.
- Department of Pediatric Pulmonology, Columbia University Irving Medical Center, New York, New York, USA.
- Department of Otolaryngology-Head and Neck Surgery, University of California, Los Angeles, California, USA.
ORCID-Profile: Jeremy P Tervo, Brandon M Moore, Hossein Sadeghi, Jonathan B Overdevest
Förderung
- This research was supported by the National Center for Advancing Translational Sciences (NCATS), the National Heart, Lung, and Blood Institute (NHLBI), and the…
- National Center for Advancing Translational Sciences
Zitieren
APA
Tervo, J. P., Moore, B. M., DiMango, E., Sadeghi, H., Keating, C., Beswick, D. M., Gudis, D. A., & Overdevest, J. B. (2025). Domain‐Specific Olfaction in Children and Adults in the Era of Modulator Therapy for Cystic Fibrosis. Pediatric Pulmonology. https://doi.org/10.1002/ppul.71348
Vancouver
Tervo JP, Moore BM, DiMango E, Sadeghi H, Keating C, Beswick DM, et al. Domain‐Specific Olfaction in Children and Adults in the Era of Modulator Therapy for Cystic Fibrosis. Pediatric Pulmonology. 2025. doi:10.1002/ppul.71348
BibTeX
@article{Tervo2025,
author = {Tervo, Jeremy P and Moore, Brandon M and DiMango, Emily and Sadeghi, Hossein and Keating, Claire and Beswick, Daniel M and Gudis, David A and Overdevest, Jonathan B},
title = {Domain‐Specific Olfaction in Children and Adults in the Era of Modulator Therapy for Cystic Fibrosis},
journal = {Pediatric Pulmonology},
year = {2025},
doi = {10.1002/ppul.71348}
}
EUVIMED